Gartner Names TraceLink as "Cool Vendor" for Supply Chain Management

WOBURN, MA, April 7, 2011 - Gartner has selected TraceLink, Inc., developer of the TraceLink Network, the world's first industry-wide supply collaboration network, as one of this year's "Cool Vendors for Supply Chain Management"*. Finally, the Life Science industry can realize the vision of a demand-driven supply chain through improved integration, information and collaboration across the supply network. As a result, manufacturing and supply chain teams can improve on-time delivery, reduce order-to-cash cycle times, improve right-first-time production, decrease inventory levels and eliminate manual data entry.

Launched in April 2010, the TraceLink Network connects all participants in the supply chain from raw material suppliers and CMO/CPO partners to Life Science companies, distribution firms and pharmacy/hospital dispensation points. Using the TraceLink Network, business owners gain the data access and operational control they need through integrated business modules such as Production Tracking, Material Tracking, Quality Review, and Inventory Monitoring.

"The TraceLink Network's ‘integrate-once, interoperate-with-everyone' information exchange platform, integrated business process modules and collaborative team workspaces have been built through close collaboration with leading pharmaceutical / biopharmaceutical companies as well as innovative supply partners such as Catalent, Patheon and Sharp," said Shabbir Dahod, President and CEO of TraceLink. "We believe our selection by Gartner is another confirmation that the TraceLink Network helps companies create strategic supply relationships and improve KPIs by integrating their supply networks to deliver precise, real-time data and shared visibility across supply operations."

To talk to one of our customers/supply partners about why they joined the TraceLink Network, see how you can improve supply chain data access for enterprise systems such as SAP and Oracle or view a demonstration of how quickly you can improve production tracking, inventory monitoring and quality review processes, visit www.tracelink.com.

*Gartner, Inc., Cool Vendors for Supply Chain Management, C. Dwight Klappich et al, March 30, 2011.

About TraceLink:

TraceLink helps companies across the Life Sciences supply chain connect and collaborate to improve manufacturing and supply chain performance through the TraceLink Network. The TraceLink Network is a Cloud-based platform that prevents counterfeits, detects diversion, minimizes inventory, reduces cycle-time and ensures on-time delivery for all members of the supply chain by integrating its participants into a network of interoperable, collaborative business processes shared across companies. Pharmaceutical/biopharmaceutical companies and their supply chain partners quickly forge high-value partnerships by connecting with an "integrate-once, interoperate with everyone" transaction platform, an integrated set of shared business objects and a collaborative team workspace based on social networking principles that puts key and actionable supply network data into the hands of business owners.

TraceLink is funded by FirstMark Capital, a venture capital firm managing more than $2 billion in capital commitments. For more information on TraceLink and our solutions, visit www.tracelink.com.

About Gartner's Cool Vendors Selection Process:

Gartner's listing does not constitute an exhaustive list of vendors in any given technology area, but rather is designed to highlight interesting, new and innovative vendors, products and services. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness of a particular purpose.

Gartner defines a cool vendor as a company that offers technologies or solutions that are: Innovative, enable users to do things they couldn't do before; Impactful, have, or will have, business impact (not just technology for the sake of technology); Intriguing, have caught Gartner's interest or curiosity in approximately the past six months.

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.